Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns
Clinical Parkinsonism & Related Disorders · 2026 · 15 · 100482
DOI: 10.1016/j.prdoa.2026.100482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Parkinsonism & Related Disorders, 2026. Verfasst von Mehri Salari und 8 weiteren Autor:innen. Beteiligte Einrichtung: Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is an increasing public health challenge in the Middle East, yet regional data on access to therapies and services remain limited. Understanding the gaps in PD treatment availability, affordability, and prescription frequency is necessary for improving care delivery and regional policy development.
Objectives
Evaluating the availability, affordability, and utilization of disease-related pharmacological treatments, surgical, device-assisted therapies, and rehabilitative services across multiple Middle Eastern countries.
Methods
A cross-sectional, web-based survey was distributed to physicians with expertise in movement disorders across participating countries in the Middle East. The survey assessed three domains of availability, cost, and utilization of key medications, surgical interventions, and specialized PD services.
Results
Thirty-one respondents from nine Middle Eastern countries, including 44% movement-disorder specialists. Medication availability was 65.4%, affordability 68.6%, and prescription 52% across the included countries. Levodopa was nearly universally available (98%), whereas newer dopamine agonists, MAO-B inhibitors, and COMT inhibitors were available inconsistently. Advanced therapies demonstrated disparities; botulinum toxin and deep-brain stimulation were available in high-income countries but not frequently used, while infusion therapies were mostly unavailable. Telemedicine uptake was moderate; genetic testing was cost-restricted. Although general rehabilitation was available, PD-specific services were limited. Affordability constrained equitable care. Qatar had the highest reported prescription frequency of PD medications among the countries.
Conclusions
The survey highlights disparities in access to essential PD therapies across the Middle East. Variable availability, costs, and limited specialized services prevent optimal care, urging the need for stronger regional policies, improved insurance coverage, and expanded clinical training to improve equity in PD management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Cleveland Clinic, Abu Dhabi, United Arab Emirates.
- Clinical Neurosciences Department, King Fahad Military Medical Complex, Dhahran, Saudi Arabia.
- Department of Rehabilitation Sciences, College of Health Sciences, Qatar University, Doha, Qatar.
- Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Neurology, Erciyes University, Faculty of Medicine, 38039 Kayseri, Turkey.
Zitieren
APA
Salari, M., Mittal, S., Aldaajani, Z., Khalil, H., Etemadifar, M., Gültekin, M., Alfwaress, F., Arain, M. I., & Soleimani, S. (2026). Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns. Clinical Parkinsonism & Related Disorders, 15, 100482. https://doi.org/10.1016/j.prdoa.2026.100482
Vancouver
Salari M, Mittal S, Aldaajani Z, Khalil H, Etemadifar M, Gültekin M, et al. Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns. Clinical Parkinsonism & Related Disorders. 2026;15:100482. doi:10.1016/j.prdoa.2026.100482
BibTeX
@article{Salari2026,
author = {Salari, Mehri and Mittal, Shivam and Aldaajani, Zakiyah and Khalil, Hanan and Etemadifar, Masoud and Gültekin, Murat and Alfwaress, Firas and Arain, Mudassar Iqbal and Soleimani, Sevim},
title = {Access to Parkinson's disease treatments in the Middle East: a multi-national survey of availability, affordability, and utilization patterns},
journal = {Clinical Parkinsonism & Related Disorders},
year = {2026},
volume = {15},
pages = {100482},
doi = {10.1016/j.prdoa.2026.100482}
}
EUVIMED